Masterclass Certificate in Ethical Drug Development: Expert Insights
-- ViewingNowThe Masterclass Certificate in Ethical Drug Development: Expert Insights is a comprehensive course that emphasizes the significance of ethical practices in the pharmaceutical industry. This certification equips learners with critical skills required to navigate the complex landscape of drug development while upholding ethical standards.
2,614+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ๅ ณไบ่ฟ้จ่ฏพ็จ
100%ๅจ็บฟ
้ๆถ้ๅฐๅญฆไน
ๅฏๅไบซ็่ฏไนฆ
ๆทปๅ ๅฐๆจ็LinkedInไธชไบบ่ตๆ
2ไธชๆๅฎๆ
ๆฏๅจ2-3ๅฐๆถ
้ๆถๅผๅง
ๆ ็ญๅพ ๆ
่ฏพ็จ่ฏฆๆ
โข Ethical Considerations in Drug Development: This unit will cover the fundamental ethical principles that guide the development of drugs, including respect for autonomy, beneficence, non-maleficence, and justice. It will also explore the role of ethical committees and regulations in ensuring the ethical conduct of drug development.
โข Pharmacovigilance and Risk Management: This unit will focus on the importance of monitoring and managing the safety of drugs throughout their development and post-marketing phases. It will cover topics such as adverse event reporting, signal detection, risk assessment, and risk minimization strategies.
โข Clinical Trial Design and Conduct: This unit will delve into the ethical considerations involved in designing and conducting clinical trials, including the selection of study populations, randomization, blinding, and informed consent. It will also cover the challenges of recruiting and retaining study participants and the importance of data integrity and transparency.
โข Compassionate Use and Expanded Access Programs: This unit will discuss the ethical dilemmas surrounding the provision of investigational drugs to patients who do not meet the eligibility criteria for clinical trials or who have exhausted all available treatment options. It will cover the regulatory framework for compassionate use and expanded access programs and the ethical principles that should guide their implementation.
โข Intellectual Property and Data Sharing: This unit will examine the ethical implications of intellectual property rights and data exclusivity for drug development. It will explore the tensions between protecting proprietary interests and promoting access to essential medicines, as well as the role of data sharing in advancing scientific knowledge and improving public health.
โข Stakeholder Engagement and Patient Advocacy: This unit will highlight the importance of engaging stakeholders, including patients, healthcare providers, and policymakers, in the drug development process. It will cover the ethical considerations involved in patient engagement and advocacy, as well as the challenges of balancing competing interests and ensuring transparency and accountability.
โข Ethical Issues in Global Drug Development: This unit will explore the unique ethical challenges of drug development in low- and middle-income
่ไธ้่ทฏ
ๅ ฅๅญฆ่ฆๆฑ
- ๅฏนไธป้ข็ๅบๆฌ็่งฃ
- ่ฑ่ฏญ่ฏญ่จ่ฝๅ
- ่ฎก็ฎๆบๅไบ่็ฝ่ฎฟ้ฎ
- ๅบๆฌ่ฎก็ฎๆบๆ่ฝ
- ๅฎๆ่ฏพ็จ็ๅฅ็ฎ็ฒพ็ฅ
ๆ ้ไบๅ ็ๆญฃๅผ่ตๆ ผใ่ฏพ็จ่ฎพ่ฎกๆณจ้ๅฏ่ฎฟ้ฎๆงใ
่ฏพ็จ็ถๆ
ๆฌ่ฏพ็จไธบ่ไธๅๅฑๆไพๅฎ็จ็็ฅ่ฏๅๆ่ฝใๅฎๆฏ๏ผ
- ๆช็ป่ฎคๅฏๆบๆ่ฎค่ฏ
- ๆช็ปๆๆๆบๆ็็ฎก
- ๅฏนๆญฃๅผ่ตๆ ผ็่กฅๅ
ๆๅๅฎๆ่ฏพ็จๅ๏ผๆจๅฐ่ทๅพ็ปไธ่ฏไนฆใ
ไธบไปไนไบบไปฌ้ๆฉๆไปฌไฝไธบ่ไธๅๅฑ
ๆญฃๅจๅ ่ฝฝ่ฏ่ฎบ...
ๅธธ่ง้ฎ้ข
่ฏพ็จ่ดน็จ
- ๆฏๅจ3-4ๅฐๆถ
- ๆๅ่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๆฏๅจ2-3ๅฐๆถ
- ๅธธ่ง่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๅฎๆด่ฏพ็จ่ฎฟ้ฎ
- ๆฐๅญ่ฏไนฆ
- ่ฏพ็จๆๆ
่ทๅ่ฏพ็จไฟกๆฏ
่ทๅพ่ไธ่ฏไนฆ
